Fatigue, treatment satisfaction and health‐related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate‐resistant prostate cancer.
Saved in:
| Title: | Fatigue, treatment satisfaction and health‐related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate‐resistant prostate cancer. |
|---|---|
| Authors: | Dearden, Lindsay1, Shalet, Natalie1, Artenie, Cristiana2, Mills, Andrew2, Jackson, Claire2, Grant, Laura3 laura.grant@adelphivalues.com, Gater, Adam3 |
| Source: | European Journal of Cancer Care. Jan2019, Vol. 28 Issue 1, pN.PAG-N.PAG. 1p. 2 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09615423 |
|---|---|
| DOI: | 10.1111/ecc.12949 |
